NitroMed (BiDil Drug Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

NitroMed (BiDil Drug Business) General Information

Description

Operator of a specialty pharmaceutical company. The company provides research and development efforts focuses on major diseases that are characterized by a deficiency in nitric oxide such as cardiovascular and inflammatory diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 6000 Fairview Road
  • Suite 610
  • Charlotte, NC 28210
  • United States
Primary Industry
Pharmaceuticals
Acquirer
JHP Pharmaceuticals
Corporate Office
  • 6000 Fairview Road
  • Suite 610
  • Charlotte, NC 28210
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NitroMed (BiDil Drug Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NitroMed (BiDil Drug Business)‘s full profile, request access.

Request a free trial

NitroMed (BiDil Drug Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NitroMed (BiDil Drug Business)‘s full profile, request access.

Request a free trial

NitroMed (BiDil Drug Business) FAQs

  • Where is NitroMed (BiDil Drug Business) headquartered?

    NitroMed (BiDil Drug Business) is headquartered in Charlotte, NC.

  • What industry is NitroMed (BiDil Drug Business) in?

    NitroMed (BiDil Drug Business)’s primary industry is Pharmaceuticals.

  • Is NitroMed (BiDil Drug Business) a private or public company?

    NitroMed (BiDil Drug Business) is a Private company.

  • What is the current valuation of NitroMed (BiDil Drug Business)?

    The current valuation of NitroMed (BiDil Drug Business) is .

  • What is NitroMed (BiDil Drug Business)’s current revenue?

    The current revenue for NitroMed (BiDil Drug Business) is .

  • Who are NitroMed (BiDil Drug Business)’s investors?

    Nitromed has invested in NitroMed (BiDil Drug Business).

  • When was NitroMed (BiDil Drug Business) acquired?

    NitroMed (BiDil Drug Business) was acquired on 23-Oct-2008.

  • Who acquired NitroMed (BiDil Drug Business)?

    NitroMed (BiDil Drug Business) was acquired by JHP Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process